Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients
Lorber, M.I.; Flechner, S.M.; Van Buren, C.T.; Kerman, R.H.; Kahan, B.D.
Transplantation Proceedings 17(4 Suppl 1: 282-285
1985
ISSN/ISBN: 0041-1345 PMID: 3895668 Document Number: 265046
Document emailed within 1 workday
Related Documents
Pallardo, L.M.; Sanchez, J.; Garcia, J.; Moreno, R.F.; Rochera, A.; Cabezuelo, J. 1988: Low doses of cyclosporine, azathioprine, and prednisone in renal transplantation: immunosuppressive efficacy and reduced nephrotoxicity Transplantation Proceedings 20(5 Suppl 6: 26-27Allegra, A.; Corica, F.; Ientile, R.; Corsonello, A.; Sparacino, V.; Accettola, F.; Caputo, F.; Macaione, S.; Buemi, M. 1998: Plasma (total and ionized), erythrocyte and platelet magnesium levels in renal transplant recipients during cyclosporine and/or azathioprine treatment Magnesium Research 11(1): 11-18
Senel, M.F.; Van Buren, C.T.; Etheridge, W.B.; Barcenas, C.; Jammal, C.; Kahan, B.D. 1996: Effects of cyclosporine, azathioprine and prednisone on Kimura's disease and focal segmental glomerulosclerosis in renal transplant patients Clinical Nephrology 45(1): 18-21
MacDonald, A.S.; Daloze, P.; Dandavino, R.; Jindal, S.; Bear, L.; Dossetor, J.B.; Klassen, J.; Stiller, C.R.; Lockwood, B.; Reeve, C.E. 1987: A randomized study of cyclosporine with and without prednisone in renal allograft recipients. Canadian Transplant Group Transplantation Proceedings 19(1 Part 3): 1865-1866
Francis, D.M.; Walker, R.G.; Jones, C.; Powell, H. 1994: Cessation of steroids in pediatric renal transplant recipients treated with cyclosporine, azathioprine, and prednisolone Transplantation Proceedings 26(1): 99-101
Thiel, G.; Mihatsch, M.; Landmann, J.; Hermle, M.; Brunner, F.P.; Harder, F. 1985: Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive? Transplantation Proceedings 17(4 Suppl 1: 169-178
Brynger, H.; Persson, H.; Flatmark, A.; Albrechtsen, D.; Frödin, L.; Tufvesson, G.; Gäbel, H.; Weibull, H.; Möller, E.; Lundgren, G. 1988: No effect of blood transfusions or HLA matching on renal graft success rate in recipients treated with cyclosporine-prednisolone or cyclosporine-azathioprine-prednisolone: the Scandinavian experience Transplantation Proceedings 20(3 Suppl 3: 261-263
Chomette, G.; Auriol, M.; Beaufils, H.; Rottemburg, J.; Cabrol, C. 1986: Morphology of cyclosporine nephrotoxicity in human heart transplant recipients Journal of Heart Transplantation 5(4): 273-278
Driscoll, D.F.; Pinson, C.W.; Jenkins, R.L.; Bistrian, B.R. 1989: Potential protective effects of furosemide against early cyclosporine-induced renal injury in hepatic transplant recipients Transplantation Proceedings 21(3): 3549-3550
Carpenter, C.B.; Milford, E.L.; Kirkman, R.L.; Strom, T.B.; Lazarus, J.M.; Tilney, N.L. 1985: Stability of renal allograft recipients after conversion from cyclosporine to azathioprine Transplantation Proceedings 17(4 Suppl 1: 261-265
Diliz, H.S.; Olivera, M.A.; Kershenobich, D.; Mercado, M.A.; Orozco, H. 1996: Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients Transplantation Proceedings 28(6): 3348-3350
Peraldi, M.N.; Rondeau, E.; Bellaj, A.; Kanfer, A.; Sraer, J.D. 1988: Association of cytomegalovirus infection and immunosuppressive treatment with cyclosporine A and antilymphocyte globulin in renal transplant recipients Clinical Nephrology 29(1): 52
Tellis, V.A.; Matas, A.J.; Quinn, T.A.; Glicklich, D.; Weiss, R.J.; Soberman, R.J.; Veith, F.J. 1987: Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients Transplantation Proceedings 19(1 Part 3): 1892
Salomon, D.R. 1991: An alternative view minimizing the significance of cyclosporine nephrotoxicity and in favor of enhanced immunosuppression for long-term kidney transplant recipients Transplantation Proceedings 23(4): 2115-2118
Lai, M.K.; Huang, C.C.; Chu, S.H.; Chuang, C.K.; Fong, M.T. 1989: Renal transplantation in hepatitis B carriers: comparison of azathioprine- and cyclosporine-treated recipients Clinical Transplants 1989: 281-286
O'Connell, P.; d'Apice, A.; Walker, R.; Francis, D.; Kincaid-Smith, P. 1988: Cessation of steroids in renal allograft recipients on combined cyclosporine A, azathioprine, and prednisolone Transplantation Proceedings 20(1): 11-13
Sukhavasharin, N.; Praditpornsilpa, K.; Avihingsanon, Y.; Kuoatawintu, P.; O-Charoen, R.; Kansanabuch, T.; Tungsanga, K.; Eiam-Ong, S. 2006: Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose Journal of the Medical Association of Thailand 89(Suppl 2): S15-S20
Sheil, A.G.; Disney, A.P.; Mathew, T.H.; Amiss, N.; Excell, L. 1991: Cancer development in cadaveric donor renal allograft recipients treated with azathioprine (AZA) or cyclosporine (CyA) or AZA/CyA Transplantation Proceedings 23(1 Part 2): 1111-1112
Ammons, M.A.; Bauling, P.C.; Weil, R. 1986: Pneumatosis cystoides intestinalis with pneumoperitoneum in renal transplant patients on cyclosporine and prednisone Transplantation Proceedings 18(6): 1868-1870
Sandrini, S.; Maiorca, R.; Scolari, F.; Cancarini, G.; Setti, G.; Gaggia, P.; Cristinelli, L.; Zubani, R.; Bonardelli, S.; Maffeis, R.; Portolani, N.; Nodari, F.; Giulini, S.M. 2000: A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation Transplantation 69(9): 1861-1867